Literature DB >> 22825774

Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study.

Andrea M Abbott1, Helen M Parsons, Todd M Tuttle, Eric H Jensen.   

Abstract

INTRODUCTION: The timing of surgical resection for stage IV colon cancer with liver metastasis and the safety of simultaneous colon and liver resection remains controversial. The purpose of our study was to evaluate short-term outcomes after combined colon and liver resection (CCLR) versus colon resection (CR) or liver resection alone (LR) using a population database.
METHODS: The National Inpatient Sample was used to select patients who had surgery for colon cancer from 2002 to 2006. We evaluated for in-hospital morbidity, mortality, and prolonged length of stay (PLOS). Our analysis was done using design-weighted unadjusted analysis and logistic regression.
RESULTS: We identified 361,096 patients during our study period (CCLR 3,625; CR 322,286; LR 35,185). CCLR was not associated with an increased risk of complications (odds ratio (OR) 1.12; 95% confidence interval (CI) 0.94-1.33; P=0.21) or PLOS (OR 1.19; 95% CI 0.99-1.4; P=0.06) compared with CR. In-hospital mortality occurred in 3.5% of patients who underwent CCLR and was not significantly associated with mortality compared with CR alone (OR 1.17; 95% CI 0.79-1.74; P=0.43). Liver lobectomy with CR was associated with a PLOS and a trend toward increased morbidity and mortality. Significant predictors of complications, mortality, and PLOS included: age>70 years, male gender, nonprivate health insurance, and Elixhauser score>1.
CONCLUSIONS: CCLR with limited liver resection can be performed with similar morbidity and mortality to colectomy alone. For patients who require hepatic lobectomy, however, strong consideration should be given to a staged approach.

Entities:  

Mesh:

Year:  2012        PMID: 22825774     DOI: 10.1245/s10434-012-2515-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection.

Authors:  Christopher R Shubert; Elizabeth B Habermann; John R Bergquist; Cornelius A Thiels; Kristine M Thomsen; Walter K Kremers; Michael L Kendrick; Robert R Cima; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2015-08-04       Impact factor: 3.452

2.  Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.

Authors:  Xi Ai; Yanhui Wu; Wei Zhang; Zhanguo Zhang; Guannan Jin; Jianping Zhao; Jingjing Yu; Youzhi Lin; Wanguang Zhang; Huifang Liang; Pran K Datta; Mingzhi Zhang; Bixiang Zhang; Xiaoping Chen
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

3.  Simultaneous resection for colorectal cancer and synchronous liver metastases.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe; Masatoshi Isogai
Journal:  Surg Today       Date:  2015-05-26       Impact factor: 2.549

4.  Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases.

Authors:  Paramin Muangkaew; Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; YoungRok Choi; Jae Yool Jang; Hanlim Choi; Jae Seong Jang; Seong Uk Kwon
Journal:  J Gastrointest Surg       Date:  2015-10-15       Impact factor: 3.452

5.  Analysis of liver-directed therapies in U.S. cancer patients.

Authors:  O B Alese; S Kim; Z Chen; S S Ramalingam; T K Owonikoko; B F El-Rayes
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

6.  Cost-Effectiveness in Hepatic Lobectomy: the Effect of Case Volume on Mortality, Readmission, and Cost of Care.

Authors:  Jeffrey M Sutton; Richard S Hoehn; Audrey E Ertel; Gregory C Wilson; Dennis J Hanseman; Koffi Wima; Jeffrey J Sussman; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2015-10-01       Impact factor: 3.452

7.  Comparison of minimally invasive and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases: a propensity score analysis.

Authors:  Qi Lin; Qinghai Ye; Dexiang Zhu; Ye Wei; Li Ren; Peng Zheng; Pingping Xu; Lechi Ye; Minzhi Lv; Jia Fan; Jianmin Xu
Journal:  Int J Colorectal Dis       Date:  2014-12-12       Impact factor: 2.571

8.  Simultaneous Resection for Synchronous Colorectal Liver Metastasis: the New Standard of Care?

Authors:  Jonathan S Abelson; Fabrizio Michelassi; Tianyi Sun; Jialin Mao; Jeffrey Milsom; Benjamin Samstein; Art Sedrakyan; Heather L Yeo
Journal:  J Gastrointest Surg       Date:  2017-04-14       Impact factor: 3.452

9.  Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.

Authors:  Ronald M van Dam; Toine M Lodewick; Maartje A J van den Broek; Mechteld C de Jong; Jan Willem Greve; Rob L H Jansen; Marc H A Bemelmans; Ulf P Neumann; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2013-11-07       Impact factor: 3.647

10.  Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer.

Authors:  Gerd R Silberhumer; Philip B Paty; Brian Denton; Jose Guillem; Mithat Gonen; Raphael L C Araujo; Garret M Nash; Larissa K Temple; Peter J Allen; Ronald P DeMatteo; Martin R Weiser; W Douglas Wong; William R Jarnagin; Michael I D'Angelica; Yuman Fong
Journal:  Surgery       Date:  2016-04-11       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.